Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug:126:184-195.
doi: 10.1016/j.placenta.2022.06.008. Epub 2022 Jul 3.

Associations between antenatal maternal asthma status and placental DNA methylation

Affiliations

Associations between antenatal maternal asthma status and placental DNA methylation

Alison G Lee et al. Placenta. 2022 Aug.

Abstract

Introduction: Maternal asthma in pregnancy is associated with adverse perinatal and child health outcomes; however, mechanisms are poorly understood.

Methods: The PRogramming of Intergenerational Stress Mechanisms (PRISM) prospective pregnancy cohort characterized asthma history during pregnancy via questionnaires and quantified placental DNAm using the Illumina Infinium HumanMethylation450 BeadChip. We performed epigenome-wide association analyses (n = 223) to estimate associations between maternal active or inactive asthma, as compared to never asthma, and placental differentially methylated positions (DMPs) and differentially variable positions (DVPs). Models adjusted for maternal pre-pregnancy body mass index, smoking status, parity, age and education level and child sex. P-values were FDR-adjusted.

Results: One hundred and fifty-nine (71.3%) pregnant women reported no history of asthma (never asthma), 15 (6.7%) reported inactive, and 49 (22%) reported active antenatal asthma. Women predominantly self-identified as Black/Hispanic Black [88 (39.5%)] and Hispanic/non-Black [42 (18.8%)]. We identified 10 probes at FDR<0.05 and 4 probes at FDR<0.10 characterized by higher variability in maternal active asthma compared to never asthma mapping to GPX3, LHPP, PECAM1, ATAD3C, and ARHGEF4 and 2 probes characterized by lower variation mapping to CHMP4A and C5orf24. Amongst women with inactive asthma, we identified 52 probes, 41 at FDR<0.05 and an additional 11 at FDR <0.10, with higher variability compared to never asthma; BMP4, LHPP, PHYHIPL, and ZSCAN23 were associated with multiple DVPs. No associations were observed with DMPs.

Discussion: We observed alterations in placental DNAm in women with antenatal asthma, as compared to women without a history of asthma. Further research is needed to understand the impact on fetal development.

Keywords: DNA methylation; Differentially variable positions; Maternal antenatal asthma; Placenta; Sex-specific effects.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest

None.

Figures

Figure 1.
Figure 1.
Volcano (a) and Manhattan plot (b) summarizing the topmost DVPs (FDR <0.10) associated with Active Asthma (red). The y-axis corresponds to −log10 p-values from DVP association testing. For (a), β represents the variance ratio comparing variation in placental DNAm for Active and Never Asthma groups.
Figure 2.
Figure 2.
Zoom-in plots (a) of gene regions for which multiple DNAm probes were associated with Active Asthma. Probes within a window of 10 KB from the topmost associated probe (red) are yellow or deeper orange if p-values were less than 0.01. (b) Density plots of the topmost DVP for each gene region illustrated in (a).
Figure 3.
Figure 3.
Volcano (a) and Manhattan plot (b) summarizing the topmost DVPs (FDR <0.10) associated with Active Asthma (red). The y-axis corresponds to −log10 p-values from DVP association testing. For (a), the x-axis is the log variance ratio comparing variation in placental DNAm for Inactive versus Never Asthma groups.
Figure 4.
Figure 4.
Zoom-in plots (a) of gene regions for which multiple DNAm probes were associated with Inactive Asthma. Probes within a window of 10 KB from the topmost associated probe (red) are yellow or deeper orange if p-values were less than 0.01. (b) Density plots of the topmost DVP for each gene region illustrated in (a).
Figure 5.
Figure 5.
Volcano and Manhattan plots of DVPs (a-b) and DMPs (c-d) with sex-specific effects for Inactive Asthma (red). The y-axis corresponds to -log10 p-values from DVP/DMP association testing, β represents the variance ratio (a) or difference in fold change (c) comparing males with Inactive Asthma to the Never Asthma group.
Fig. 6.
Fig. 6.
Zoom-in plots for BMP4 gene region with multiple sex-specific DVPs (a) and DMPs (b) for Inactive Asthma. (b) Density plot for topmost DNAm probe with both sex-specific DVP and DMP associations for BMP4. (c) Heatmap of genes associated with Active and/or Inactive Asthma. M-values correspond to the topmost probe or the topmost common probe (if associated in multiple models).

References

    1. Kwon HL, Belanger K, Bracken MB, Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys, Ann. Epidemiol 13 (5) (2003) 317–324. - PubMed
    1. Murphy V, Wang G, Namazy J, Powell H, Gibson P, Chambers C, et al., The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis, BJOG An Int. J. Obstet. Gynaecol 120 (7) (2013) 812–822. - PubMed
    1. Namazy JA, Murphy VE, Powell H, Gibson PG, Chambers C, Schatz M, Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes, Eur. Respir. J 41 (5) (2013) 1082–1090. - PubMed
    1. Wang G, Murphy VE, Namazy J, Powell H, Schatz M, Chambers C, et al., The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis, J. Matern. Fetal Neonatal Med 27 (9) (2014) 934–942. - PubMed
    1. Cowell WJ, Bellinger DC, Wright RO, Wright RJ, Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children, Brain Behav. Immun 80 (2019) 871–878. - PMC - PubMed

Publication types

Substances